June 18-19, 2018: Acobiom will attend the 3rd International Conference on Pancreatic Cancer and Liver Diseases (Roma, Italy). David Piquemal (CSO) will make a presentation concerning: « Patient Stratification and Precision Medicine in Pancreatic cancer ».
February 3-7, 2018: Toulouse Onco Week (TOW, Toulouse, France). ACOBIOM will attend to this event and present the GemciTest, A New In-Vitro Diagnostic to predict the response to Gemcitabine treatment in Pancreatic Cancer.
December 14-15, 2017: ONCO Emergence forum (Montpellier, France). ACOBIOM will attend to the Partnering session of the ONCO Emergence forum, networking conference focused on setting up transnational collaborative projects in Oncology.
November 30th, 2017: 11th edition of Eurobiomed Carrefour: Omics Sciences for the medicine of Tomorrow (Marseille, France). During the session « Genomic medicine, innovative technologies for an early diagnosis », David Piquemal presented the Acobiom experience in the Pancreatic Cancer.
May 16-17, 2017: European HPC Summit Week 2017 in Barcelona. The Acobiom’s MaRS (Matrix of RNAseq) database and its manager, Fabien Pierrat, have been awarded for best industrial presentation at the PRACE days 2017, under the motto “HPC for Innovation: when Science meets Industry”.